Accessibility Menu

Instinct Bio Technical(NASDAQ) BIOTW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2026)-71%
5 YearN/A
1 YearN/A
1 Month-13%
$0.02
-0.57%
-0.00Today
Instinct Bio Technical last closing stock price
MetricPriceDate
Last closeUSD 0.022026-08-31
Instinct Bio Technical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-12.5%USD 0.022026-08-24
1 month-12.5%USD 0.022026-07-31
Since inception-70.83%USD 0.062026-07-24

Instinct Bio Technical Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-4.38 (Low)

Price

$0.02

Volume

614.761

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.37

Estimated Earnings Date

N/A

BIOTW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Instinct Bio Technical

Instinct Bio Technical Company Holdings Inc. Warrants is an integrated regenerative medicine and longevity company. The focus lies in the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.

Products and Services
  • Regenerative health technologies aimed at improving patient outcomes
  • Stem cell-derived products for various therapeutic applications
  • Advanced skincare solutions leveraging innovative biotechnology
Growth Outlook
  • Market demand for regenerative medicine is projected to grow significantly
  • Increasing investments in biotechnology are expected to drive innovation
  • Potential partnerships could enhance product development and market reach
Financial Highlights
  • Current market capitalization stands at approximately $75,310
  • Recent stock price range between $0.0175 and $0.0245
  • Trailing twelve months (TTM) data indicates a negative P/E ratio of -1.05
Instinct Bio Technical Company Holdings Inc. operates in the dynamic biotechnology sector, which is characterized by rapid advancements and increasing consumer interest in health and wellness. The company's focus on regenerative medicine positions it well to capitalize on the growing market demand. Recent trends indicate a robust interest in innovative health solutions, which could provide significant opportunities for growth. The financial highlights reflect a current market capitalization that suggests potential for future appreciation, despite the challenges indicated by the negative P/E ratio. Overall, the company is strategically positioned to leverage its expertise in regenerative health technologies and advanced skincare to meet evolving consumer needs.
AI Generated • Aug 26, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

Grand Cayman, KY1-9009, US

BIOTW Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-121755.40%

Return on Capital

N/A

Return on Assets

-5279160.73%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

614.761

Avg. Volume

93.09K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Instinct Bio Technical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About BIOTW

What is the current price of Instinct Bio Technical?

Instinct Bio Technical is trading at $0.02 per share.

What is the 52-week range for Instinct Bio Technical?

Over the past 52 weeks, Instinct Bio Technical has traded between $0.02 and $0.37.

How much debt does Instinct Bio Technical have?

Instinct Bio Technical total debt is unavailable.

How much cash does Instinct Bio Technical have on hand?

Instinct Bio Technical does not have cash on hand data available.

What is Instinct Bio Technical’s dividend yield?

Instinct Bio Technical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services